MIMEDX GROUP, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| HAWKINS WILLIAM A | — | Award / Grant | 35,354 | $4.95 | $175,002 | 152,219 | Jun 13, 2023 |
| Newton Todd | — | Award / Grant | 35,354 | $4.95 | $175,002 | 360,972 | Jun 13, 2023 |
| LAURENCIN CATO T | — | Award / Grant | 35,354 | $4.95 | $175,002 | 130,124 | Jun 13, 2023 |
| Stein Robert Benjamin | President, Regenerative Med. | Sale | 10,365 | $5.95 | $61,672 | 317,803 | May 15, 2023 |
| Hulse William Frank IV | General Counsel and CAO | Sale | 5,870 | $5.93 | $34,809 | 456,564 | May 10, 2023 |
| Stein Robert Benjamin | President, Regenerative Med. | Sale | 5,869 | $5.93 | $34,803 | 331,775 | May 10, 2023 |
| Phelan William Lawrence | Chief Accounting Officer | Sale | 1,595 | $5.93 | $9,458 | 184,219 | May 10, 2023 |
| Carlson Peter M | Chief Financial Officer | Sale | 5,976 | $5.93 | $35,438 | 656,435 | May 10, 2023 |
| Stein Robert Benjamin | President, Regenerative Med. | Sale | 51,756 | $5.34 | $276,377 | 337,644 | May 4, 2023 |
| Phelan William Lawrence | Chief Accounting Officer | Sale | 5,200 | $3.80 | $19,760 | 185,814 | May 2, 2023 |
| Phelan William Lawrence | Chief Accounting Officer | Sale | 1,628 | $3.74 | $6,089 | 191,014 | Apr 25, 2023 |
| Stein Robert Benjamin | President, Regenerative Med. | Sale | 5,987 | $3.74 | $22,391 | 389,400 | Apr 25, 2023 |
| Hulse William Frank IV | General Counsel and CAO | Sale | 5,988 | $3.74 | $22,395 | 462,434 | Apr 25, 2023 |
| Carlson Peter M | Chief Financial Officer | Sale | 6,094 | $3.74 | $22,792 | 662,411 | Apr 25, 2023 |
| Phelan William Lawrence | Chief Accounting Officer | Sale | 1,632 | $3.31 | $5,402 | 192,642 | Apr 11, 2023 |
| Stein Robert Benjamin | President, Regenerative Med. | Sale | 5,996 | $3.31 | $19,847 | 395,387 | Apr 11, 2023 |
| Hulse William Frank IV | General Counsel and CAO | Sale | 5,995 | $3.31 | $19,843 | 468,422 | Apr 11, 2023 |
| Carlson Peter M | Chief Financial Officer | Sale | 6,100 | $3.31 | $20,191 | 668,505 | Apr 11, 2023 |
| Stein Robert Benjamin | President, Regenerative Med. | Award / Grant | 135,065 | $4.62 | $624,000 | 401,383 | Mar 13, 2023 |
| Carlson Peter M | Chief Financial Officer | Award / Grant | 140,455 | $4.62 | $648,902 | 674,605 | Mar 13, 2023 |
| Phelan William Lawrence | Chief Accounting Officer | Award / Grant | 53,030 | $4.62 | $244,999 | 194,274 | Mar 13, 2023 |
| Hulse William Frank IV | General Counsel and CAO | Award / Grant | 136,364 | $4.62 | $630,002 | 474,417 | Mar 13, 2023 |
| Stein Robert Benjamin | President, Regenerative Med. | Sale | 12,355 | $4.24 | $52,385 | 266,318 | Mar 7, 2023 |
| Phelan William Lawrence | Chief Accounting Officer | Sale | 3,396 | $4.24 | $14,399 | 141,244 | Mar 7, 2023 |
| Carlson Peter M | Chief Financial Officer | Sale | 12,056 | $4.24 | $51,117 | 534,150 | Mar 7, 2023 |
| Hulse William Frank IV | General Counsel and CAO | Sale | 11,308 | $4.24 | $47,946 | 338,053 | Mar 7, 2023 |
| Carlson Peter M | Chief Financial Officer | Sale | 19,000 | $4.50 | $85,500 | 546,206 | Feb 23, 2023 |
| Hulse William Frank IV | General Counsel and CAO | Sale | 15,555 | $4.53 | $70,464 | 349,361 | Feb 23, 2023 |
| Whitlow Ricci S | Chief Operating Officer | Award / Grant | 462,857 | $3.50 | $1,620,000 | 462,857 | Feb 13, 2023 |
| Carlson Peter M | Chief Financial Officer | Sale | 4,992 | $2.82 | $14,077 | 565,206 | Dec 22, 2022 |
| Newton Todd | Interim CEO | Award / Grant | 200,000 | — | — | 325,618 | Sep 15, 2022 |
| Stein Robert Benjamin | President, Regenerative Med. | Sale | 19,000 | $3.44 | $65,360 | 287,002 | Sep 13, 2022 |
| Stein Robert Benjamin | President, Regenerative Med. | Sale | 8,503 | $4.04 | $34,352 | 306,002 | Aug 12, 2022 |
| Kashyap Rohit | President, WC & Surgical | Sale | 12,343 | $4.21 | $51,964 | 430,072 | Aug 9, 2022 |
| Stein Robert Benjamin | President, Regenerative Med. | Sale | 19,500 | $3.62 | $70,590 | 314,505 | Aug 4, 2022 |
| Stein Robert Benjamin | President, Regenerative Med. | Sale | 14,600 | $3.47 | $50,662 | 334,005 | Jun 28, 2022 |
| Giuliani Michael J | — | Award / Grant | 44,191 | $3.96 | $174,996 | 94,770 | Jun 10, 2022 |
| WRIGHT TIMOTHY R | Chief Executive Officer | Sale | 112,000 | $3.75 | $420,000 | 1,711,324 | Jun 9, 2022 |
| Newton Todd | — | Award / Grant | 44,191 | $3.96 | $174,996 | 125,618 | Jun 7, 2022 |
| LAURENCIN CATO T | — | Award / Grant | 44,191 | $3.96 | $174,996 | 94,770 | Jun 7, 2022 |
| HAWKINS WILLIAM A | — | Award / Grant | 44,191 | $3.96 | $174,996 | 116,865 | Jun 7, 2022 |
| GARDNER PHYLLIS | — | Award / Grant | 44,191 | $3.96 | $174,996 | 81,670 | Jun 7, 2022 |
| BIERMAN JAMES L | — | Award / Grant | 44,191 | $3.96 | $174,996 | 125,618 | Jun 7, 2022 |
| BEHRENS M KATHLEEN | — | Award / Grant | 44,191 | $3.96 | $174,996 | 125,618 | Jun 7, 2022 |
| Graves Mark | SVP & Chief Compliance Officer | Sale | 3,891 | $3.50 | $13,619 | 133,608 | May 9, 2022 |
| Phelan William Lawrence | Chief Accounting Officer | Sale | 5,750 | $3.81 | $21,908 | 144,640 | May 6, 2022 |
| Turner Scott M | SVP, Operations & Procurement | Sale | 5,260 | $4.00 | $21,040 | 226,643 | May 2, 2022 |
| WRIGHT TIMOTHY R | Chief Executive Officer | Award / Grant | 602,679 | $4.62 | $2,784,377 | 1,823,324 | Apr 8, 2022 |
| Hulse William Frank IV | General Counsel and CAO | Award / Grant | 178,571 | $4.62 | $824,998 | 364,916 | Apr 8, 2022 |
| Graves Mark | SVP & Chief Compliance Officer | Award / Grant | 48,485 | $4.62 | $224,001 | 137,499 | Apr 8, 2022 |